15-Hydroxyprostaglandin dehydrogenase protein expression in human fetal membranes with and without subclinical inflammation

Reproductive Sciences

Volumn 14, Issue 3, 2007, Pages 260-269

  Rizek, Rose M ^b   Watson, Carole S ^b   Keating, Sarah ^b   Tai, Hsin Hsiung ^b   Challis, John R G ^b   Bocking, Alan D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Fetal membranes; Inflammation; Preterm birth; Preterm premature rupture of membranes; Prostaglandin dehydrogenase

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTIBODY; DIAGNOSTIC AGENT; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS; FETUS MEMBRANE; GESTATION PERIOD; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACUTE DISEASE; AMNION; ANALYSIS OF VARIANCE; CHORIOAMNIONITIS; CHORION; COMPARATIVE STUDY; ENZYMOLOGY; INFLAMMATION; MESODERM; METABOLISM; PATHOLOGY; PREGNANCY; PREMATURE LABOR; PREMATURITY; TROPHOBLAST; WESTERN BLOTTING;

ACUTE DISEASE; ADULT; AMNION; ANALYSIS OF VARIANCE; ANTIBODIES; BLOTTING, WESTERN; CHORIOAMNIONITIS; CHORION; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISOENZYMES; MESODERM; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; TROPHOBLASTS;

EID: 35348908080     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107302433     Document Type: Article

References (45)

1. Kramer MS, Demissie K., Yang H., Platt RW, Sauve R., Liston R. The contribution of mild and moderate preterm birth to infant mortality. JAMA. 2000 ; 284: 843-849.
2. Gilbert WM, Nesbitt TS, Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol. 2003 ; 102: 488-492.
3. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG. 2003 ; 110: 3-7.
4. Slattery MM, Morrison JJ Preterm delivery. Lancet. 2002 ; 360: 1489-1497.
5. Vergani P., Patane L., Doria P., et al. Risk factors for neonatal intraventricular haemorrhage in spontaneous prematurity at 32 weeks gestation or less. Placenta. 2000 ; 21: 402-407.
6. Luig M., Lui K., NSW & ACT NICUS Group. Epidemiology of nectrotizing enterocolitis-part I: changing regional trends in extremely preterm infants over 14 years. J Paediatr Child Health. 2005 ; 41: 169-173.
7. Moutquin J-M. Classification and heterogeneity of preterm birth. BJOG. 2003 ; 110: 30-33.
8. Kramer MS The epidemiology of adverse pregnancy outcomes: an overview. J Nutr. 2003 ; 133: 1592S - 1596S.
9. Goldenberg RL, Hauth JC, Andrews WW Intrauterine infection and preterm delivery. N Engl J Med. 2000 ; 342: 1500-1507.
10. Kraus FT, Redline RW, Gersell DJ Inflammation and infection. In: Kraus FT, Redline RW, Gersell DJ, eds. Placental Pathology. Washington, DC: Armed Forces Institute of Pathology ; 2004: 75-92.
11. Sebire NJ, Goldin RD, Regan L. Histological chorioamnionitis in relation to clinical presentation at 14-40 weeks of gestation. J Obstet Gynaecol. 2001 ; 21: 242-245.
12. Romero R., Manogue KR, Mitchell MD, et al. Infection and labor IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol. 1989 ; 161: 336-341.
13. Rizzo G., Capponi A., Rinaldo D., Tedeschi D., Arduini D., Romanini C. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1996 ; 175: 812-817.
14. Pomini F., Caruso A., Challis JR Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J Clin Endocrinol Metab. 1999 ; 84: 4645-4651.
15. Winkler M. Role of cytokines and other inflammatory mediators. BJOG. 2003 ; 110: 118-123.
16. Challis Jrg, Matthews SG, Gibb W., Lye SJ Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000 ; 21: 514-550.
17. Polzin WJ, Brady K. The etiology of premature rupture of the membranes. Clin Obstet Gynecol. 1998 ; 41: 810-816.
18. Teixeira FJ, Zakar T., Hirst JJ, et al. Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J Clin Endocrinol Metab. 1994 ; 78: 1396-1402.
19. Keirse MJ, Turnbull AC The fetal membranes as a possible source of amniotic fluid prostaglandins. Br J Obstet Gynaecol. 1976 ; 83: 146-151.
20. Challis JR, Patel FA, Pomini F. Prostaglandin dehydrogenase and the initiation of labor. J Perinat Med. 1999 ; 27: 26-34.
21. Okita RT, Okita JR Prostaglandin-metabolizing enzymes during pregnancy: characterization of NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase. Crit Rev Biochem Mol Biol. 1996 ; 31: 101-126.
22. Anggard E., Larsson C., Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand. 1971 ; 81: 396-404.
23. Cheung PY, Walton JC, Tai HH, Riley SC, Challis JR Immunocytochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta. Am J Obstet Gynecol. 1990 ; 163: 1445-1449.
24. Giannoulias D., Patel FA, Holloway AC, Lye SJ, Tai HH, Challis JR Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium. J Clin Endocrinol Metab. 2002 ; 87: 1345-1352.
25. Cheung PY, Walton JC, Tai HH, Riley SC, Challis JR Localization of 15-hydroxy prostaglandin dehydrogenase in human fetal membranes, decidua, and placenta during pregnancy. Gynecol Obstet Invest. 1992 ; 33: 142-146.
26. Keirse MJ, Turnbull AC Metabolism of prostaglandins within the pregnant uterus. Br J Obstet Gynaecol. 1975 ; 82: 887-893.
27. Sangha RK, Walton JC, Ensor CM, Tai HH, Challis JR Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab. 1994 ; 78: 982-989.
28. van Meir CA, Matthews SG, Keirse MJ, Ramirez MM, Bocking A., Challis JR 15-hydroxyprostaglandin dehydrogenase: implications in preterm labor with and without ascending infection. J Clin Endocrinol Metab. 1997 ; 82: 969-976.
29. Okazaki T., Casey ML, Okita JR, MacDonald PC, Johnston JM Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am J Obstet Gynecol. 1981 ; 139: 373-381.
30. Germain AM, Smith J., Casey ML, MacDonald PC. Human fetal membrane contribution to the prevention of parturition: uterotonin degradation. J Clin Endocrinol Metab. 1994 ; 78: 463-470.
31. Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254.
32. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685.
33. Krook M., Marekov L., Jornvall H. Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase: the primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. Biochemistry. 1990 ; 29: 738-743.
34. Thaler-Dao H., Saintot M., Baudin G., Descomps B., Crastes de Paulet A. Placental 15-hydroxyprostaglandin dehydrogenase binding site requirements. Adv Prostaglandin Thromboxane Res. 1976 ; 1: 177-182.
35. Cho H., Tai HH Threonine 11 of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD(+) during catalysis. Prostaglandins Leukot Essent Fatty Acids. 2002 ; 66: 505-509.
36. Mitchell MD, Sato TA Effects of altering DNA methylation and histone acetylation status on enzymes of eicosanoid biosynthesis in human gestational tissues. J Soc Gynecol Investig. 2005 ; 12: 289A.
37. Amos LA, Amos WB Molecules of the Cytoskeleton. Basingstoke, UK: MacMillan Education ; 1991.
38. Carraway KL, Carraway CA, Carraway KL III. Signaling and the Cytoskeleton. Berlin, Germany: Springer ; 1998.
39. Welch MD, Mullins RD Cellular control of actin nucleation. Annu Rev Cell Dev Biol. 2002 ; 18: 247-288.
40. Arias F., Victoria A., Cho K., Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997 ; 89: 265-271.
41. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005 ; 192: 1162-1166.
42. Tsigelny I., Baker ME Structures stabilizing the dimer interface on human 11 beta-hydroxysteroid dehydrogenase types 1 and 2 and human 15-hydroxyprostaglandin dehydrogenase and their homologs. Biochem Biophys Res Commun. 1995 ; 217: 859-868.
43. Chang WC, Wu HL, Hsu SY, Chen FS Isolation of rat renal NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Prostaglandins Leukot Essent Fatty Acids. 1990 ; 41: 19-25.
44. Hohl W., Stahl B., Mundkowski R., et al. Mass determination of 15-hydroxyprostaglandin dehydrogenase from human placenta and kinetic studies with (5Z, 8E, 10E, 12S)-12-hydroxy-5,8,10-heptadecatrienoic acid as substrate. Eur J Biochem. 1993 ; 214: 67-73.
45. Lamont RF Recent evidence associated with the condition of preterm prelabour rupture of the membranes. Curr Opin Obstet Gynecol. 2003 ; 15: 91-99.